Peutz-Jeghers syndrome and the pancreas — what an STK11 change actually means

Peutz-Jeghers syndrome is an inherited condition caused by a change in a single tumour-suppressor gene, STK11. Two things usually bring it to attention. The first is dark, freckle-like pigment spots on the lips, inside the mouth, and sometimes on the fingers and toes — they often appear in childhood and fade during adult life. The second is a particular kind of growth called a hamartomatous polyp, which develops in the small bowel, stomach and colon, and which can cause bleeding, anaemia, or a bowel that folds in on itself and obstructs.

If you have been told you carry an STK11 change, or you have looked up Peutz Jeghers pancreatic cancer after a diagnosis in the family, this page is written for you. It goes one level deeper than the general hereditary picture set out in is pancreatic cancer hereditary? and stays on this one syndrome.

The syndrome runs in an autosomal dominant pattern. Each child of someone who carries the altered gene has a one-in-two chance of inheriting it, and the pigment spots or the polyps often show up long before anyone thinks about cancer at all. It also arises new, in people with no affected relative anywhere in the family tree, which is why a clean family history does not rule it out.

What makes a largely gastrointestinal condition relevant to an oncology service is simple. STK11 does not only govern the gut. Losing one working copy of it raises the lifetime risk of several cancers, and the pancreas is one of the organs most affected. That single fact is why a diagnosis usually made by a gastroenterologist ends up being managed, in part, by cancer specialists.

• Dark pigment spots on the lips or inside the mouth that appeared in childhood, particularly alongside gut polyps, unexplained anaemia or repeated abdominal pain.
• A pathology report that describes a polyp as hamartomatous, or specifically as Peutz-Jeghers type. That wording is the single most useful thing to look for on an old report.
• An episode of intussusception, or repeated bowel obstruction, in childhood or early adult life — especially if a polyp was found at the time.
• A close blood relative with a confirmed STK11 change. Predictive testing is available to relatives, and this is the clearest reason of all to book.
• Several different cancers in the family at unusually young ages — the wider version of that question is answered in is pancreatic cancer hereditary?
• You already know you carry the change but have never been offered pancreatic monitoring. That is worth correcting — see screening for people at high risk of pancreatic cancer.

1. 1

   A free 45-minute consultation, not a five-minute triage

   We take the family history properly — who was affected, at what stage of life, on which side of the family, and what the pathology reports actually said. With a syndrome this specific, the old reports usually matter more than anything anyone can recall in the room.

   In-house at CION
2. 2

   Genetic counselling, before and after any test

   Counselling comes first, so you know in advance what a result would mean for you, for your children and for your siblings — and what it would not mean. Where testing is appropriate we arrange it, then go through the report with you line by line.

   In-house at CION
3. 3

   Pancreatic surveillance imaging, ordered and reported here

   MRI with MRCP, pancreatic-protocol CT where it adds something, CA 19-9 and routine bloods are ordered and reported by CION across 35+ centres. CA 19-9 on its own is not a screening test, and we will say so rather than keep repeating it to settle an anxiety.

   In-house at CION
4. 4

   Endoscopy, endoscopic ultrasound and biopsy

   Upper endoscopy, colonoscopy, small-bowel studies, endoscopic ultrasound and any biopsy taken through it are arranged with specialist gastroenterology and endoscopy partner centres, and may be billed there. We book them, read the results with you, and hold the plan together.

   Coordinated with specialist partner centres
5. 5

   If anything is ever found

   Chemotherapy, radiation, nutrition and enzyme support, pain control and psycho-oncology care are delivered by CION. All pancreatic surgery is coordinated with specialist HPB partner surgeons and may be billed at those centres. The full pathway is set out in pancreatic cancer treatment in Hyderabad.

   Split: in-house and coordinated

Carrying an STK11 change is not a diagnosis of cancer, and it is not a prediction. Most people who carry it do not develop pancreatic cancer. What it does is move you out of the group for whom nothing is offered and into the small group for whom structured monitoring is genuinely worthwhile — and that is a better position to be in, not a worse one.

Here is the uncomfortable part, stated plainly. Pancreatic surveillance is imperfect. It does not catch everything, it turns up findings that come to nothing, and it asks you to keep attending appointments for years for results that will almost always be normal. Nobody should pretend otherwise. It is still worth doing, because pancreatic cancer found early enough to be removed is a completely different situation from pancreatic cancer found late, and surveillance is the only realistic route to the first of those.

The second thing worth saying is that monitoring does not replace paying attention. Painless yellowing of the eyes or skin needs checking within the same week, whether or not you are on a surveillance programme. So does unexplained weight loss, or persistent upper abdominal pain that bores through to the back. A scan already booked for some months ahead is not a reason to wait with a new symptom.

And the third: a syndrome diagnosis is family information, not only personal information. Siblings, children and sometimes cousins can be tested if they choose to be, and a relative who turns out not to carry the change ends the question for their branch of the family permanently. That is often the most useful result the whole process produces. If you want the broader context first, our complete pancreatic cancer guide covers the wider picture, and is pancreatic cancer hereditary? sets out how the inherited syndromes compare with one another.

Medical disclaimer: This page explains Peutz-Jeghers syndrome and its relationship to pancreatic cancer risk in general terms, and is reviewed by a CION medical oncologist with reference to NCCN guidance on genetic and familial risk assessment and to international CAPS consensus criteria on pancreatic surveillance in high-risk individuals. It is general information and not a risk calculation for any individual; your own monitoring plan should be agreed with a clinical genetics and oncology team who know your history. Risk assessment, genetic counselling, pancreatic-protocol CT, MRI/MRCP, CA 19-9 and routine bloods, medical and radiation oncology, nutrition and enzyme (PERT) support, pain, psycho-oncology and survivorship care are delivered by CION. Upper endoscopy, colonoscopy and small-bowel studies, endoscopic ultrasound and biopsy, ERCP and biliary stenting, staging laparoscopy, PET-CT and all pancreatic surgery are coordinated with specialist HPB, gastroenterology and endoscopy partner centres and may be billed there.